Methanol recovery: potential of nanolaminate organic solvent nanofiltration (OSN) membranes.

Researchers have made a significant breakthrough by merging the energy-saving attribute of organic solvent nanofiltration (OSN) with the remarkable solvent permeance and solute rejection of two-dimensional (2D) laminated membranes. This innovative approach brings forth a new era of sustainable and cost-effective separation techniques, presenting a promising solution to the issue of industrial solvents contaminating the environment. This development paves the way for new opportunities in building a sustainable future. Specifically, our mini-review has cast a spotlight on the separation and recovery of methanol-a solvent abundantly used in industrial processes. We systematically evaluated a diverse array of free-standing 2D nanolaminate OSN membranes. The analysis encompasses the assessment of pure methanol permeance, solute rejection capabilities, and the simultaneous evaluation of methanol permeance and solute rejection performance. Notably, this study sheds light on the considerable potential of 2D laminated OSN membranes in revolutionizing separation processes for the industrial use of methanol.

Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis.

Toxic epidermal necrolysis (TEN) is a life-threatening cutaneous adverse drug reaction. To better understand why skin symptoms are so severe, we conducted a prospective immunophenotyping study on skin and blood. Mass cytometry results confirmed that effector memory polycytotoxic CD8+ T cells (CTLs) are the main leucocytes in TEN blisters at the acute phase. Deep T cell receptor (TCR) repertoire sequencing identified massive expansion of unique CDR3 clonotypes in blister cells. The same clones were highly expanded in patient's blood, and the degree of their expansion showed significant correlation with disease severity. By transducing α and ß chains of the expanded clonotypes into a TCR-defective cell line, we confirmed that those cells were drug specific. Collectively, these results suggest that the relative clonal expansion and phenotype of skin-recruited CTLs condition the clinical presentation of cutaneous adverse drug reactions.